BDBM237551 US10052306, 222::rac-2-(2-(3-fluoro-4- hydroxyphenyl)-2- hydroxyethyl)-5- (thiophen-2- ylmethyl)octahydrocyclo- penta[c]pyrrol-5-ol

SMILES OC(CN1C[C@H]2C[C@](O)(Cc3cccs3)C[C@H]2C1)c1ccc(O)c(F)c1

InChI Key InChIKey=QZPCSULOKOSWNR-IWHGBRQISA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 237551   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM237551(US10052306, 222 | rac-2-(2-(3-fluoro-4- hydroxyphe...)
Affinity DataIC50:  19.3nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent